Skip to main content

Advertisement

SpringerLink
Log in

Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases?

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Several studies have shown that acromegaly is associated with increased psychological morbidity. However, it is not known whether this is attributed to acromegaly per se or to its chronicity as a debilitating disease affecting quality of life (QoL). The aim of this study was to assess psychological profile in acromegalics compared with those suffering from other serious chronic diseases and healthy controls. Secondary end points were QoL assessment and its association with mood disturbances. Comparative, cross-sectional study conducted in Northern Greece (2011–2012). The Greek versions of the Profile of Mood States (POMS) and AcroQoL questionnaires were used to assess psychological status and QoL, respectively. Forty acromegalics, 40 age- and sex-matched people with other chronic diseases and 80 healthy controls were included. No significant differences were identified between acromegalics and those suffering from other chronic diseases, regarding tension, anger, depression, confusion, fatigue and vigor. Compared with healthy controls, acromegalics suffered more from depression and anger, which remained significant after controlling for age, gender and marital status (p = 0.003 and p = 0.048, respectively). Negative predictors were female gender, macroadenomas and radiotherapy. AcroQoL scores were negatively associated with POMS subscales. Males had better QoL than females. Other than a negative association between AcroQoL-relationships subscale and disease duration, no association with other parameters was observed. Acromegaly has a negative impact on psychological status, which is worse than that of general population, but comparable to other chronic diseases. Mood disturbances are associated with impaired QoL, mainly in females and those with longer disease duration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. P. Anagnostis, Z.A. Efstathiadou, S.A. Polyzos, F. Adamidou, A. Slavakis, M. Sapranidis, I.D. Litsas, S. Katergari, D. Selalmatzidou, M. Kita, Acromegaly: presentation, morbidity and treatment outcomes at a single centre. Int. J. Clin. Pract. 65, 896–902 (2011)

    Article  PubMed  CAS  Google Scholar 

  2. P. Anagnostis, Z.A. Efstathiadou, S. Gougoura, S.A. Polyzos, E. Karathanasi, P. Dritsa, M. Kita, G.N. Koukoulis, Oxidative stress and reduced antioxidative status, along with endothelial dysfunction in acromegaly. Horm. Metab. Res. 45, 314–318 (2013)

    PubMed  CAS  Google Scholar 

  3. L.J. Woodhouse, A. Mukherjee, S.M. Shalet, S. Ezzat, The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocr. Rev. 27, 287–317 (2006)

    Article  PubMed  CAS  Google Scholar 

  4. T.J. Reid, K.D. Post, J.N. Bruce, M. Nabi Kanibir, C.M. Reyes-Vidal, P.U. Freda, Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin. Endocrinol. (Oxf) 72, 203–208 (2010)

    Article  Google Scholar 

  5. S.M. Webb, Quality of life in acromegaly. Neuroendocrinology 83, 224–229 (2006)

    Article  PubMed  CAS  Google Scholar 

  6. S.C. Hua, Y.H. Yan, T.C. Chang, Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly. Eur. J. Endocrinol. 155, 831–837 (2006)

    Article  PubMed  CAS  Google Scholar 

  7. M.P. Matta, E. Couture, L. Cazals, D. Vezzosi, A. Bennet, P. Caron, Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance. Eur. J. Endocrinol. 158, 305–310 (2008)

    Article  PubMed  CAS  Google Scholar 

  8. J. Leon-Carrion, J.F. Martin-Rodriguez, A. Madrazo-Atutxa, A. Soto-Moreno, E. Venegas-Moreno, E. Torres-Vela, P. Benito-López, M.A. Gálvez, F.J. Tinahones, A. Leal-Cerro, Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly. J. Clin. Endocrinol. Metab. 95, 4367–4379 (2010)

    Article  PubMed  CAS  Google Scholar 

  9. C. Sievers, M. Ising, H. Pfister, C. Dimopoulou, H.J. Schneider, J. Roemmler, J. Schopohl, G.K. Stalla, Personality in patients with pituitary adenomas is characterized by increased anxiety-related traits: comparison of 70 acromegalic patients with patients with non-functioning pituitary adenomas and age- and gender-matched controls. Eur. J. Endocrinol. 160, 367–373 (2009)

    Article  PubMed  CAS  Google Scholar 

  10. A. Margo, Acromegaly and depression. Br. J. Psychiatry 139, 467–468 (1981)

    Article  PubMed  CAS  Google Scholar 

  11. A. Giustina, P. Chanson, M.D. Bronstein, A. Klibanski, S. Lamberts, F.F. Casanueva, P. Trainer, E. Ghigo, K. Ho, S. Melmed, Acromegaly Consensus Group, A consensus on criteria for cure of acromegaly. J. Clin. Endocrinol. Metab. 95, 3141–3148 (2010)

    Article  PubMed  CAS  Google Scholar 

  12. P. Anagnostis, F. Adamidou, S.A. Polyzos, Z. Efstathiadou, A. Panagiotou, M. Kita, Non-functioning pituitary adenomas: a single center experience. Exp. Clin. Endocrinol. Diabetes 119, 314–319 (2011)

    Article  PubMed  CAS  Google Scholar 

  13. D.M. McNair, M. Lorr, L.F. Droppleman, EITS manual for the Profile of Mood States (Educational and Industrial Testing Service, San Diego, CA, 1971)

    Google Scholar 

  14. K.W. Wyrwich, H. Yu, Validation of POMS questionnaire in postmenopausal women. Qual. Life Res. 20, 1111–1121 (2011)

    Article  PubMed  Google Scholar 

  15. F. Baker, M. Denniston, J. Zabora, A. Polland, W.N. Dudley, A POMS short form for cancer patients: psychometric and structural evaluation. Psychooncology 11, 273–281 (2002)

    Article  PubMed  Google Scholar 

  16. S.M. Webb, L. Prieto, X. Badia, M. Albareda, M. Catala, S. Gaztambide, T. Lucas, C. Páramo, A. Pico, A. Lucas, I. Halperin, G. Obiols, R. Astorga, Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin. Endocrinol. (Oxf) 57, 251–258 (2002)

    Article  CAS  Google Scholar 

  17. S.M. Webb, X. Badia, N.L. Surinach, Spanish AcroQol Study Group, Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. Eur. J. Endocrinol. 155, 269–277 (2006)

    Article  PubMed  CAS  Google Scholar 

  18. R. Kauppinen-Mäkelin, T. Sane, H. Sintonen, H. Markkanen, M.J. Välimäki, E. Löyttyniemi, L. Niskanen, A. Reunanen, U.H. Stenman, Quality of life in treated patients with acromegaly. J. Clin. Endocrinol. Metab. 91, 3891–3896 (2006)

    Article  PubMed  Google Scholar 

  19. C. Sardella, M. Lombardi, G. Rossi, C. Cosci, S. Brogioni, I. Scattina, S.M. Webb, M. Gasperi, E. Martino, F. Bogazzi, Short- and long-term changes of quality of life in patients with acromegaly: results from a prospective study. J. Endocrinol. Invest. 33, 20–25 (2010)

    Article  PubMed  CAS  Google Scholar 

  20. S.K. Mattoo, A.K. Bhansali, N. Gupta, S. Grover, R. Malhotra, Psychosocial morbidity in acromegaly: a study from India. Endocrine 34, 17–22 (2008)

    Article  PubMed  CAS  Google Scholar 

  21. A. Miller, H. Doll, J. David, J. Wass, Impact of musculoskeletal disease on quality of life in long-standing acromegaly. Eur. J. Endocrinol. 158, 587–593 (2008)

    Article  PubMed  CAS  Google Scholar 

  22. Yedinak, C.G., Fleseriu, M. Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: a pilot study. Endocrine. (2013). doi:10.1007/s12020-013-0106-9

  23. T. Psaras, M. Milian, V. Hattermann, B.E. Will, M. Tatagiba, J. Honegger, Predictive factors for neurocognitive function and Quality of Life after surgical treatment for Cushing’s disease and acromegaly. J. Endocrinol. Invest. 34, e168–e177 (2011)

    Article  PubMed  CAS  Google Scholar 

  24. M. Ruchala, I. Stangierska, E. Gurgul, A. Stangierski, J. Fajfer, J. Sowinski, The effect of octreotide treatment on somatic and psychological symptoms of acromegaly. Neuro. Endocrinol. Lett. 31, 265–269 (2010)

    PubMed  CAS  Google Scholar 

  25. C. Sievers, P.G. Sämann, T. Dose, C. Dimopoulou, D. Spieler, J. Roemmler, J. Schopohl, M. Mueller, H.J. Schneider, M. Czisch, H. Pfister, G.K. Stalla, Macroscopic brain architecture changes and white matter pathology in acromegaly: a clinicoradiological study. Pituitary. 12, 177–185 (2009)

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  26. M. Ziegenbein, K. Held, H.E. Kuenzel, H. Murck, I.A. Antonijevic, A. Steiger, The somatostatin analogue octreotide impairs sleep and decreases EEG sigma power in young male subjects. Neuropsychopharmacology 29, 146–151 (2004)

    Article  PubMed  CAS  Google Scholar 

  27. A.M. Peiffer, C.M. Leyrer, D.M. Greene-Schloesser, E. Shing, W.T. Kearns, W.H. Hinson, S.B. Tatter, E.H. Ip, S.R. Rapp, M.E. Robbins, E.G. Shaw, M.D. Chan, Neuroanatomical target theory as a predictive model for radiation-induced cognitive decline. Neurology. 80, 747–753 (2013)

    Article  PubMed  PubMed Central  Google Scholar 

  28. N.P. Maric, M. Doknic, D. Pavlovic, S. Pekic, M. Stojanovic, M. Jasovic-Gasic, V. Popovic, Psychiatric and neuropsychological changes in growth hormone-deficient patients after traumatic brain injury in response to growth hormone therapy. J. Endocrinol. Invest. 33, 770–775 (2010)

    Article  PubMed  CAS  Google Scholar 

  29. M.J. Wassenaar, N.R. Biermasz, M. Kloppenburg, A.A. van der Klaauw, J. Tiemensma, J.W. Smit, A.M. Pereira, F. Roelfsema, H.M. Kroon, J.A. Romijn, Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients. Growth Horm IGF Res. 20, 226–233 (2010)

    Article  PubMed  CAS  Google Scholar 

  30. S. Siegel, C. Streetz-van der Werf, J.S. Schott, K. Nolte, W. Karges, I. Kreitschmann-Andermahr, Diagnostic delay is associated with psychosocial impairment in acromegaly. Pituitary. 16, 507–514 (2013)

    Article  PubMed  Google Scholar 

  31. A. Raappana, T. Pirilä, T. Ebeling, P. Salmela, H. Sintonen, J. Koivukangas, Long-term health-related quality of life of surgically treated pituitary adenoma patients: a descriptive study. ISRN. Endocrinol. 2012, 675310 (2012)

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  32. R. Trepp, R. Everts, C. Stettler, S. Fischli, S. Allemann, S.M. Webb, E.R. Christ, Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the acromegaly quality of life questionnaire (AcroQoL). Clin. Endocrinol. (Oxf) 63, 103–110 (2005)

    Article  Google Scholar 

  33. N.R. Biermasz, S.W. van Thiel, A.M. Pereira, H.C. Hoftijzer, A.M. van Hemert, J.W.A. Smit, J.A. Romijn, F. Roelfsema, Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J. Clin. Endocrinol. Metab. 89, 5369–5376 (2004)

    Article  PubMed  CAS  Google Scholar 

  34. M.R. Postma, R.T. Netea-Maier, G. van den Berg, J. Homan, W.J. Sluiter, M.A. Wagenmakers, A.C. van den Bergh, B.H. Wolffenbuttel, A.R. Hermus, A.P. van Beek, Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly. Eur. J. Endocrinol. 166, 585–592 (2012)

    Article  PubMed  CAS  Google Scholar 

  35. A.A. van der Klaauw, N.R. Biermasz, H.C. Hoftijzer, A.M. Pereira, J.A. Romijn, Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly. Clin. Endocrinol. (Oxf) 69, 123–128 (2008)

    Article  Google Scholar 

  36. T. Wexler, L. Gunnell, Z. Omer, K. Kuhlthau, C. Beauregard, G. Graham, A.L. Utz, B. Biller, L. Nachtigall, J. Loeffler, B. Swearingen, A. Klibanski, K.K. Miller, Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly. J. Clin. Endocrinol. Metab. 94, 2471–2477 (2009)

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Conflicts of interest

The authors have no conflict of interest to disclose.

Author information

Authors and Affiliations

  1. Department of Endocrinology, Hippokration Hospital of Thessaloniki, Sarantaporou 10, 54640, Thessaloniki, Greece

    Panagiotis Anagnostis, Zoe A. Efstathiadou, Despina Selalmatzidou, Eleni Karathanasi, Maria Poulasouchidou & Marina Kita

  2. Department of Psychology, School of Philosophy, Aristotle University of Thessaloniki, Thessaloniki, Greece

    Maria Charizopoulou

Authors
  1. Panagiotis Anagnostis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zoe A. Efstathiadou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria Charizopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Despina Selalmatzidou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eleni Karathanasi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maria Poulasouchidou
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Marina Kita
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Panagiotis Anagnostis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anagnostis, P., Efstathiadou, Z.A., Charizopoulou, M. et al. Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases?. Endocrine 47, 564–571 (2014). https://doi.org/10.1007/s12020-014-0166-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-014-0166-5

Keywords

Search

Navigation